Last10K.com

Rti Surgical, Inc. (RTIX) SEC Filing 10-K Annual report for the fiscal year ending Monday, December 31, 2018

Rti Surgical, Inc.

CIK: 1100441 Ticker: RTIX

Exhibit 99.1

 

LOGO

Press Release

RTI Surgical® Announces Fourth Quarter and Full Year 2018 Results

Results in Line with Guidance Driven by Operational Excellence Initiatives and Growth in Spine and OEM Franchises

ALACHUA, Fla., February 28, 2019 – RTI Surgical, Inc. (Nasdaq: RTIX), a global surgical implant company, reported operating results for the fourth quarter and full year of 2018.

Fourth Quarter 2018 Highlights:

 

   

Revenue increased to $71.2 million

 

   

Net income of $2.1 million, inclusive of $1.0 million of net non-recurring expenses

 

   

Adjusted EBITDA of $7.7 million, or 11% of revenue

Full Year 2018 Highlights:

 

   

2018 revenues increased to $280.9 million

 

   

Net loss of $3.4 million, inclusive of $11.0 million of net non-recurring expenses

 

   

Adjusted EBITDA of $33.7 million, or 12% of revenue

 

   

Provides 2019 revenue guidance

“Our fourth quarter and full year 2018 results demonstrate solid financial performance resulting from consistent progress across our key strategic initiatives,” stated Camille Farhat, President and CEO. “We believe the ongoing successful efforts to reduce complexity and drive operational excellence, including significant cost reduction efforts in tissue manufacturing, are providing the foundation to accelerate RTI’s growth. In 2018, we returned OEM to growth and continued to transition customers to long-term partners signaling the strength of our relationships and importance of our products to our partners. Further, the definitive agreement to acquire Paradigm Spine, announced in November 2018 and anticipated to close in early March, will contribute to the formidable platform of differentiated spine implants we established in 2018.”

Farhat continued, “We believe our accomplishments in 2018 have provided an exceptionally strong foundation to support our performance in 2019 and beyond. Our investment in rebuilding the spine pipeline has revitalized our new product development efforts, which we anticipate will serve as a catalyst for organic growth starting in 2020. We will work to continue to reduce the complexity of our business and extend operational excellence throughout the Company to accelerate the growth trajectory of RTI. We expect our performance will be driven by the successful integration of Paradigm, disciplined R&D efforts and the continued exploration of acquisition opportunities. We are excited for the year ahead.”

Fourth Quarter 2018

RTI’s worldwide revenues for the fourth quarter of 2018 were $71.2 million, compared with $70.8 million during the same period in the prior year. Gross profit for the fourth quarter of 2018 was $38.7 million, or 54.4% of revenues, a significant increase compared to $36.3 million, or 51.2% of revenues, in the fourth quarter of 2017.

During the fourth quarter of 2018, RTI incurred non-recurring pre-tax charges to support the ongoing strategic transformation of the business. The Company incurred $2.2 million in


The following information was filed by Rti Surgical, Inc. (RTIX) on Thursday, February 28, 2019 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-K Annual Report statement of earnings and operation as management may choose to highlight particular information in the press release.

View differences made from one year to another to evaluate Rti Surgical, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Rti Surgical, Inc..

Continue

Assess how Rti Surgical, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Rti Surgical, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Rating

Learn More
Bullish Bearish Neutral
Filter Sentiment:
All
Positive
Negative
Filter Category:
All
Financial
Revenue
M & A
Other
Filter Subcategory:
All
Expense
Product
Shares
Debt
Earnings
Income
Dividend
Geography
Other
Inside Rti Surgical, Inc.'s 10-K Annual Report:

Financial Statements, Disclosures and Schedules

Inside this 10-K Annual Report

Document And Entity Information
Consolidated Balance Sheets
Consolidated Balance Sheets (Parenthetical)
Consolidated Statements Of Cash Flows
Consolidated Statements Of Comprehensive (Loss) Income
Consolidated Statements Of Stockholders' Equity
Accrued Expenses
Accrued Expenses (Tables)
Accrued Expenses - Accrued Expenses (Detail)
Acquisition Of Zyga Technology Inc. - Acquisition Purchase Price (Detail)
Acquisition Of Zyga Technology Inc. - Additional Information (Detail)
Acquisition Of Zyga Technology Inc. - Pro Forma Information Of Company's Operations (Detail)
Acquisition Of Zyga Technology Inc. - Summary Of Allocation Of Total Consideration To Tangible And Intangible Assets And Liabilities (Detail)
Acquisition Of Zyga Technology, Inc.
Acquisition Of Zyga Technology, Inc. (Tables)
Business
Cardiothoracic Closure Business Divestiture
Cardiothoracic Closure Business Divestiture (Tables)
Cardiothoracic Closure Business Divestiture - Additional Information (Detail)
Cardiothoracic Closure Business Divestiture - Schedule Of Calculation Of Gain Of Ct Business Divestiture (Detail)
Commitments And Contingencies
Commitments And Contingencies (Tables)
Commitments And Contingencies - Additional Information (Detail)
Commitments And Contingencies - Future Minimum Lease Commitments Under Non-Cancelable Operating Leases (Detail)
Concentrations Of Risk
Concentrations Of Risk (Tables)
Concentrations Of Risk - Additional Information (Detail)
Concentrations Of Risk - Schedule Of Percentage Of Total Revenues Derived From Company's Largest Distributors And International Distribution (Detail)
Executive Transition Costs
Executive Transition Costs - Additional Information (Detail)
Executive Transition Costs - Schedule Of Restructuring Charges (Detail)
Fair Value Information
Fair Value Information (Tables)
Fair Value Information - Additional Information (Detail)
Fair Value Information - Summary Of Impairments Of Long-Lived Assets And Related Post Impairment Fair Values (Detail)
Goodwill
Goodwill (Tables)
Goodwill - Additional Information (Detail)
Goodwill - Schedule Of Goodwill (Detail)
Income Taxes
Income Taxes (Tables)
Income Taxes - Additional Information (Detail)
Income Taxes - Deferred Tax Assets And Liabilities (Detail)
Income Taxes - Effective Tax Rate Differs From The Statutory Federal Income Tax Rate (Detail)
Income Taxes - Income Tax Benefit (Provision) (Detail)
Income Taxes - Unrecognized Tax Benefits (Detail)
Inventories
Inventories (Tables)
Inventories - Additional Information (Detail)
Inventories - Components Of Inventories (Detail)
Legal And Regulatory Actions
Legal And Regulatory Actions - Additional Information (Detail)
Other Intangible Assets
Other Intangible Assets (Tables)
Other Intangible Assets - Additional Information (Detail)
Other Intangible Assets - Components Of Other Intangible Assets (Detail)
Other Intangible Assets - Estimates Of Future Amortization Expense (Detail)
Preferred Stock
Preferred Stock (Tables)
Preferred Stock - Additional Information (Detail)
Preferred Stock - Schedule Of Preferred Stock (Detail)
Prepaid And Other Current Assets
Prepaid And Other Current Assets (Tables)
Prepaid And Other Current Assets - Schedule Of Prepaid And Other Current Assets (Detail)
Property, Plant And Equipment
Property, Plant And Equipment (Tables)
Property, Plant And Equipment - Additional Information (Detail)
Property, Plant And Equipment - Components Of Property, Plant And Equipment (Detail)
Quarterly Results Of Operations (Unaudited)
Quarterly Results Of Operations (Unaudited) (Tables)
Quarterly Results Of Operations (Unaudited) - Results Of Operations (Detail)
Recently Issued Accounting Standards
Recently Issued Accounting Standards (Tables)
Recently Issued Accounting Standards - Additional Information (Detail)
Recently Issued Accounting Standards - Contract With Customer, Asset And Liability (Detail)
Recently Issued Accounting Standards - Impact Of Adoption Of Topic 606 To Consolidated Balance Sheets And Consolidated Statements Of Comprehensive (Loss) Income (Detail)
Recently Issued Accounting Standards - Impact Of Adoption Of Topic 606 To Consolidated Statements Of Comprehensive (Loss) Income (Detail)
Recently Issued Accounting Standards - Revenue Recognition From Four Franchises (Detail)
Recently Issued Accounting Standards - Schedule Of Prior Period Adjustments (Detail)
Retirement Benefits
Retirement Benefits - Additional Information (Detail)
Schedule Ii - Valuation And Qualifying Accounts
Schedule Ii - Valuation And Qualifying Accounts (Detail)
Segment Data
Segment Data (Tables)
Segment Data - Additional Information (Detail)
Segment Data - Revenues From Tissue Distribution And Other Revenues (Detail)
Segment Data - Schedule Of Property, Plant And Equipment - Net By Significant Geographic Location (Detail)
Severance And Restructuring Costs
Severance And Restructuring Costs (Tables)
Severance And Restructuring Costs - Additional Information (Detail)
Severance And Restructuring Costs - Schedule Of Restructuring Charges (Detail)
Short And Long-Term Obligations
Short And Long-Term Obligations (Tables)
Short And Long-Term Obligations - Additional Information (Detail)
Short And Long-Term Obligations - Short And Long-Term Obligations (Detail)
Stock-Based Compensation
Stock-Based Compensation (Tables)
Stock-Based Compensation - Additional Information (Detail)
Stock-Based Compensation - Other Information Concerning Stock Options (Detail)
Stock-Based Compensation - Stock Options Outstanding, Exercisable And Available For Grant (Detail)
Stock-Based Compensation - Stock-Based Compensation Recognized (Detail)
Stock-Based Compensation - Unvested Restricted Stock Awards (Detail)
Stock-Based Compensation - Weighted-Average Assumptions Used To Determine Fair Value Of Options (Detail)
Stockholders' Equity
Stockholders' Equity - Additional Information (Detail)
Subsequent Events
Summary Of Significant Accounting Policies
Summary Of Significant Accounting Policies (Policies)
Summary Of Significant Accounting Policies (Tables)
Summary Of Significant Accounting Policies - Additional Information (Detail)
Summary Of Significant Accounting Policies - Property, Plant, And Equipment Are Stated At Cost Less Accumulated Depreciation (Detail)
Summary Of Significant Accounting Policies - Reconciliation Of Common Stock Used In Calculation Of Basic And Diluted Earnings Per Share (Detail)
Ticker: RTIX
CIK: 1100441
Form Type: 10-K Annual Report
Accession Number: 0001193125-19-063391
Submitted to the SEC: Tue Mar 05 2019 5:12:54 AM EST
Accepted by the SEC: Tue Mar 05 2019
Period: Monday, December 31, 2018
Industry: Orthopedic Prosthetic And Surgical Appliances And Supplies

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/rtix/0001193125-19-063391.htm